Literature DB >> 16241910

Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes.

A J Lee1, C Ll Morgan, M Morrissey, K U Wittrup-Jensen, T Kennedy-Martin, C J Currie.   

Abstract

AIMS: The purpose of this study was to characterize the impact of body mass index (BMI) on health-related utility for patients with Type 1 and Type 2 diabetes and those without diabetes.
METHODS: The study was conducted in Cardiff and the Vale of Glamorgan, Wales, UK. Health-related utility was measured using the EQ-5D(index). Patients from the Health Outcomes Data Repository (HODaR) were surveyed by postal questionnaire either 6 weeks post discharge for in-patients or at out-patient clinics between January 2002 and July 2003. BMI was calculated from self-reported data within the survey. Patients with diabetes were identified by a previous history of an in-patient admission with diabetes or as an out-patient with diabetes recorded as a coexisting diagnosis.
RESULTS: Questionnaires were returned from 27 924 patients of whom 2575 had diabetes. Increasing BMI was found to reduce utility in all three groups. BMI was significantly greater for those with Type 2 diabetes compared with those with Type 1, and those without diabetes (P < 0.001). Multiple regression analysis demonstrated that both BMI and diabetes status had a significant effect on utility. However, the rate of change of utility attributable to BMI was not found to be significantly different between the various groups.
CONCLUSIONS: Obesity negatively impacts upon health-related utility and thus quality of life for all patient groups. There was no significant difference in the effect of obesity on utility between those with and without diabetes.

Entities:  

Mesh:

Year:  2005        PMID: 16241910     DOI: 10.1111/j.1464-5491.2005.01657.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  28 in total

1.  Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.

Authors:  Melanie J Davies; Divina Glah; Barrie Chubb; Gerasimos Konidaris; Phil McEwan
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981

2.  The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy.

Authors:  C J Currie; C D Poole; A Woehl; C Ll Morgan; S Cawley; M D Rousculp; M T Covington; J R Peters
Journal:  Diabetologia       Date:  2006-08-30       Impact factor: 10.122

Review 3.  The economics of diabetes prevention.

Authors:  William H Herman
Journal:  Med Clin North Am       Date:  2011-03       Impact factor: 5.456

Review 4.  A systematic review and critical assessment of health state utilities: weight change and type 2 diabetes mellitus.

Authors:  Scott Doyle; Andrew Lloyd; Lee Moore; Joshua Ray; Alastair Gray
Journal:  Pharmacoeconomics       Date:  2012-12-01       Impact factor: 4.981

5.  Association between glycated hemoglobin and health utility for Type 1 diabetes.

Authors:  R Brett McQueen; Samuel L Ellis; David M Maahs; Heather D Anderson; Kavita V Nair; Anne M Libby; Jonathan D Campbell
Journal:  Patient       Date:  2014       Impact factor: 3.883

6.  Health utilities for children and adults with type 1 diabetes.

Authors:  Joyce M Lee; Kirsten Rhee; Michael J O'grady; Anirban Basu; Aaron Winn; Priya John; David O Meltzer; Craig Kollman; Lori M Laffel; Jean M Lawrence; William V Tamborlane; Tim Wysocki; Dongyuan Xing; Elbert S Huang
Journal:  Med Care       Date:  2011-10       Impact factor: 2.983

7.  Cost-effectiveness of bariatric surgical procedures for the treatment of severe obesity.

Authors:  Bruce C M Wang; Edwin S Wong; Rafael Alfonso-Cristancho; Hao He; David R Flum; David E Arterburn; Louis P Garrison; Sean D Sullivan
Journal:  Eur J Health Econ       Date:  2013-03-24

8.  Patient-reported outcomes in the practice-based opportunities for weight reduction (POWER) trial.

Authors:  R R Rubin; M Peyrot; N-Y Wang; J W Coughlin; G J Jerome; S L Fitzpatrick; W L Bennett; A Dalcin; G Daumit; N Durkin; Y-T Chang; H-C Yeh; T A Louis; L J Appel
Journal:  Qual Life Res       Date:  2013-03-21       Impact factor: 4.147

9.  Utilities and disutilities for type 2 diabetes treatment-related attributes.

Authors:  Louis S Matza; Kristina S Boye; Nicole Yurgin; Jessica Brewster-Jordan; Sally Mannix; Jodi M Shorr; Beth L Barber
Journal:  Qual Life Res       Date:  2007-07-19       Impact factor: 4.147

Review 10.  A review of health utilities across conditions common in paediatric and adult populations.

Authors:  Jean-Eric Tarride; Natasha Burke; Matthias Bischof; Robert B Hopkins; Linda Goeree; Kaitryn Campbell; Feng Xie; Daria O'Reilly; Ron Goeree
Journal:  Health Qual Life Outcomes       Date:  2010-01-27       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.